{"id":56482,"date":"2025-12-15T17:17:11","date_gmt":"2025-12-15T11:47:11","guid":{"rendered":"https:\/\/matribhumisamachar.com\/en\/?p=56482"},"modified":"2025-12-15T17:17:11","modified_gmt":"2025-12-15T11:47:11","slug":"ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india","status":"publish","type":"post","link":"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/","title":{"rendered":"Ozempic\u00ae &#8211; world\u2019s most prescribed GLP-1 is now available in India"},"content":{"rendered":"<p style=\"text-align: center;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-56483\" src=\"https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc-300x200.jpg 300w, https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc-1024x683.jpg 1024w, https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc-768x512.jpg 768w, https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc-1536x1024.jpg 1536w, https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc.jpg 1600w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<ul>\n<li style=\"text-align: justify;\"><em>Ozempic<sup>\u00ae<\/sup>\u2014a once-weekly injectable formulation of semaglutide\u2014is approved in India for adults with type 2 diabetes as the first line treatment, adjunct to diet and exercise.<\/em><\/li>\n<li style=\"text-align: justify;\"><em>While effectively reducing blood sugar, Ozempic<sup>\u00ae <\/sup>is clinically proven to provide compelling weight-loss benefits in people with diabetes<\/em><\/li>\n<li style=\"text-align: justify;\"><em>In addition to powerful HbA1C control and weight benefits, additional benefits of Ozempic<sup>\u00ae<\/sup>include cardiovascular &amp; kidney protection in people with diabetes.<\/em><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><em>\u00a0<\/em><\/p>\n<p style=\"text-align: justify;\"><strong>New Delhi, December 12, 2025<\/strong>: Novo Nordisk, a global healthcare company, today announced the launch of <strong>Ozempic<sup>\u00ae<\/sup> (injectable semaglutide)<\/strong> in India. Ozempic\u00ae is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living with<strong>uncontrolled type 2 diabetes mellitus (T2DM)<\/strong>.<\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">The arrival of Ozempic\u00ae in India comes at a crucial time. According to the World Health Organisation\u2019s 2023-24 estimates, <strong>India has 101 million <\/strong>(roughly 11.4 % of India\u2019s population) <strong>people living with diabetes<a href=\"#_ftn1\" name=\"_ftnref1\">[1]<\/a><\/strong>, making it the second largest diabetes-affected populations in the world after China. The country also has <strong>136 million individuals with prediabetes and 254 million people living with generalised obesity<\/strong>, signalling an accelerating health challenge that requires effective, evidence-based therapies.<a href=\"#_ftn2\" name=\"_ftnref2\">[2]<\/a><\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">Clinical benefits of Ozempic<sup>\u00ae<\/sup>:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Demonstrated <strong>powerful HbA1c reduction<\/strong> with <strong>compelling weight-loss benefits<\/strong>, supporting better metabolic health<\/li>\n<li>Suitable for adults with <strong>HbA1c \u2265=7%<\/strong>, including those with high cardiovascular risk or established cardiovascular disease<\/li>\n<li>Provides additional <strong>lowering of cardiovascular events<\/strong>, a key concern for people with long-standing T2DM<\/li>\n<li>Offers <strong>protection against chronic kidney disease progression<\/strong>, supporting long-term health outcomes<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><em>\u00a0<\/em><\/p>\n<p style=\"text-align: justify;\"><em>\u201c<\/em><em>Bringing Ozempic\u00ae to India is a major milestone\u201d <\/em><u>said Vikrant Shrotriya &#8211; Managing Director, Novo Nordisk India<\/u><em>. \u201c<\/em><em>Backed by global trust, proven clinical excellence &amp; world class quality, reinforced by a robust supply chain, Ozempic\u00ae offers Indian doctors an effective treatment choice. Our goal is to provide patients an innovative &amp; accessible therapy that offers improved glycaemic control, meaningful weight management and long-term heart and kidney protection \u2013 all delivered through a simple, easy-to-use pen device. This once-weekly treatment demonstrates Novo Nordisk\u2019s ongoing commitment to better health outcomes and chronic disease care.\u201d<\/em><\/p>\n<p style=\"text-align: justify;\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>How does Ozempic<sup>\u00ae<\/sup> work? <\/strong><\/p>\n<p style=\"text-align: justify;\">Ozempic\u00ae is a GLP-1 receptor agonist that helps:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Improve glycaemic control and reduce HbA1c<\/li>\n<li>Regulate appetite and food intake by acting on areas of the brain that control hunger<\/li>\n<li>Support weight loss in people with T2DM<\/li>\n<li>Reduce risks of cardiovascular and kidney complications associated with diabetes<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Its once-weekly administration and globally trusted safety profile make it a preferred treatment option in clinical practice across several countries.<\/p>\n<p style=\"text-align: justify;\">Ozempic\u00ae, the original GLP-1 RA (semaglutide) therapy, has been researched and developed by Novo Nordisk for over 20 years and is backed by over 38 million patient-years of global clinical use. Semaglutide was recently included in WHO\u2019s Model List of Essential Medicines &#8211; highlighting the proven health benefits of this innovative treatment for people living with diabetes and obesity.<\/p>\n<p style=\"text-align: justify;\">Ozempic\u00ae is now available in India as 0.25 mg, 0.5 mg and 1 mg in FlexTouch\u00aePen &#8211; an easy-to-use, once-weekly pen device. The multiple dosing strengths support physician-guided titration and long-term diabetes management.<\/p>\n<p style=\"text-align: justify;\"><strong><em>About Novo Nordisk India Pvt. Ltd.<\/em><\/strong><\/p>\n<p style=\"text-align: justify;\">Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 78,500 people in 80 countries and markets its products in around 170 countries. Novo Nordisk&#8217;s B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).<\/p>\n<p style=\"text-align: justify;\">For more information, visit our website- <a href=\"https:\/\/www.novonordisk.co.in\/\">novonordisk.co.in<\/a><\/p>\n<p style=\"text-align: justify;\">Follow us on <a href=\"http:\/\/www.facebook.com\/novonordisk\">Facebook<\/a>, <a href=\"https:\/\/twitter.com\/NovoNordiskIN\/status\/1618457480195117061\">Twitter<\/a>, <a href=\"https:\/\/www.linkedin.com\/company\/novo-nordisk\/mycompany\/\">LinkedIn<\/a> and <a href=\"https:\/\/www.youtube.com\/@novonordisk\">YouTube<\/a>.<\/p>\n<p style=\"text-align: justify;\"><a href=\"#_ftnref1\" name=\"_ftn1\">[1]<\/a><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12104079\/\">Chauhan S, Khatib MN, Ballal S, Bansal P, Bhopte K, Gaidhane AM, Tomar BS, Ashraf A, Kumar MR, Chauhan AS, Shabil M. The rising burden of diabetes and state-wise variations in India: insights from the Global Burden of Disease Study 1990\u20132021 and projections to 2031. Frontiers in Endocrinology. 2025 May 12;16:1505143.<\/a><\/p>\n<p style=\"text-align: justify;\"><a href=\"#_ftnref2\" name=\"_ftn2\">[2]<\/a> Anjana RM et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). The Lancet Diabetes &amp; Endocrinology. 2023 Jul 1;11(7):474-89.<\/p>\n<p>Featured ARTICLE<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ozempic\u00ae\u2014a once-weekly injectable formulation of semaglutide\u2014is approved in India for adults with type 2 diabetes as the first line treatment, adjunct to diet and exercise. While effectively reducing blood sugar, Ozempic\u00ae is clinically proven to provide compelling weight-loss benefits in people with diabetes In addition to powerful HbA1C control and weight benefits, additional benefits of &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[31202,31201],"class_list":["post-56482","post","type-post","status-publish","format-standard","","category-business-english-news","tag-novo-nordisk-india","tag-ozempic"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ozempic\u00ae - world\u2019s most prescribed GLP-1 is now available in India - Matribhumi Samachar English<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ozempic\u00ae - world\u2019s most prescribed GLP-1 is now available in India - Matribhumi Samachar English\" \/>\n<meta property=\"og:description\" content=\"Ozempic\u00ae\u2014a once-weekly injectable formulation of semaglutide\u2014is approved in India for adults with type 2 diabetes as the first line treatment, adjunct to diet and exercise. While effectively reducing blood sugar, Ozempic\u00ae is clinically proven to provide compelling weight-loss benefits in people with diabetes In addition to powerful HbA1C control and weight benefits, additional benefits of &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/\" \/>\n<meta property=\"og:site_name\" content=\"Matribhumi Samachar English\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-15T11:47:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc-300x200.jpg\" \/>\n<meta name=\"author\" content=\"Saransh Kanaujia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saransh Kanaujia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/\",\"name\":\"Ozempic\u00ae - world\u2019s most prescribed GLP-1 is now available in India - Matribhumi Samachar English\",\"isPartOf\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\"},\"datePublished\":\"2025-12-15T11:47:11+00:00\",\"dateModified\":\"2025-12-15T11:47:11+00:00\",\"author\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\"},\"breadcrumb\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/matribhumisamachar.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ozempic\u00ae &#8211; world\u2019s most prescribed GLP-1 is now available in India\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/\",\"name\":\"Matribhumi Samachar English\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\",\"name\":\"Saransh Kanaujia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"caption\":\"Saransh Kanaujia\"},\"description\":\"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.\",\"sameAs\":[\"https:\/\/matribhumisamachar.com\/en\"],\"url\":\"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ozempic\u00ae - world\u2019s most prescribed GLP-1 is now available in India - Matribhumi Samachar English","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/","og_locale":"en_US","og_type":"article","og_title":"Ozempic\u00ae - world\u2019s most prescribed GLP-1 is now available in India - Matribhumi Samachar English","og_description":"Ozempic\u00ae\u2014a once-weekly injectable formulation of semaglutide\u2014is approved in India for adults with type 2 diabetes as the first line treatment, adjunct to diet and exercise. While effectively reducing blood sugar, Ozempic\u00ae is clinically proven to provide compelling weight-loss benefits in people with diabetes In addition to powerful HbA1C control and weight benefits, additional benefits of &hellip;","og_url":"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/","og_site_name":"Matribhumi Samachar English","article_published_time":"2025-12-15T11:47:11+00:00","og_image":[{"url":"https:\/\/matribhumisamachar.com\/en\/wp-content\/uploads\/2025\/12\/WhatsApp-Image-2025-12-15-at-15.54.38_197282fc-300x200.jpg"}],"author":"Saransh Kanaujia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Saransh Kanaujia","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/","url":"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/","name":"Ozempic\u00ae - world\u2019s most prescribed GLP-1 is now available in India - Matribhumi Samachar English","isPartOf":{"@id":"https:\/\/matribhumisamachar.com\/en\/#website"},"datePublished":"2025-12-15T11:47:11+00:00","dateModified":"2025-12-15T11:47:11+00:00","author":{"@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1"},"breadcrumb":{"@id":"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/matribhumisamachar.com\/en\/2025\/12\/15\/ozempic-worlds-most-prescribed-glp-1-is-now-available-in-india\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/matribhumisamachar.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ozempic\u00ae &#8211; world\u2019s most prescribed GLP-1 is now available in India"}]},{"@type":"WebSite","@id":"https:\/\/matribhumisamachar.com\/en\/#website","url":"https:\/\/matribhumisamachar.com\/en\/","name":"Matribhumi Samachar English","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1","name":"Saransh Kanaujia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","caption":"Saransh Kanaujia"},"description":"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.","sameAs":["https:\/\/matribhumisamachar.com\/en"],"url":"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/"}]}},"_links":{"self":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/56482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/comments?post=56482"}],"version-history":[{"count":1,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/56482\/revisions"}],"predecessor-version":[{"id":56484,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/56482\/revisions\/56484"}],"wp:attachment":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/media?parent=56482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/categories?post=56482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/tags?post=56482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}